Log in

GW Pharmaceuticals PLC- Earnings Date, Estimates & History

-1.83 (-1.79 %)
(As of 09/18/2020 12:00 AM ET)
Today's Range
Now: $100.18
50-Day Range
MA: $110.03
52-Week Range
Now: $100.18
Volume659,018 shs
Average Volume462,337 shs
Market Capitalization$3.11 billion
P/E RatioN/A
Dividend YieldN/A


GW Pharmaceuticals PLC- (NASDAQ:GWPH) Earnings Information

GW Pharmaceuticals PLC- last announced its earnings results on August 6th, 2020. The biopharmaceutical company reported ($0.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.02. The firm had revenue of $121.30 million for the quarter, compared to analysts' expectations of $94.57 million. Its revenue for the quarter was up 68.4% compared to the same quarter last year. GW Pharmaceuticals PLC- has generated ($0.24) earnings per share over the last year. GW Pharmaceuticals PLC- has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 3rd, 2020 based off prior year's report dates.

GW Pharmaceuticals PLC- Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

GW Pharmaceuticals PLC- (NASDAQ:GWPH) Earnings Estimates

2020 EPS Consensus Estimate: ($0.72)
2021 EPS Consensus Estimate: $6.42
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20205($1.31)($0.36)($0.74)
Q2 20204($0.60)$0.12($0.16)
Q3 20204($0.72)$0.72($0.01)
Q4 20204($0.84)$0.96$0.18
Q1 20212$0.72$1.32$1.02
Q2 20211$1.56$1.56$1.56
Q3 20211$1.80$1.80$1.80
Q4 20211$2.04$2.04$2.04

GW Pharmaceuticals PLC- (NASDAQ GWPH) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/6/20206/30/2020($0.04)($0.02)($0.28)$94.57 million$121.30 millionTranscript
5/11/20203/31/2020($0.88)($0.24)($0.24)$84.93 million$120.60 millionTranscript
2/25/202012/31/2019($0.52)($0.84)($0.84)$80.92 million$109.10 millionTranscript
11/5/2019Q3 2019($0.87)($0.48)($0.48)$86.84 million$90.97 millionN/A
8/6/2019Q2($1.74)($0.78)($4.10)$37.28 million$72.04 millionN/A
5/6/20193/31/2019($2.48)($1.68)($1.68)$12.32 million$39.20 millionTranscript
2/26/2019Q4 2018($2.97)($2.35)($2.35)$7.10 million$6.65 millionN/A
11/27/20189/30/2018($2.48)($2.76)($2.76)$2.62 million$2.40 millionListen
8/7/20186/30/2018($2.40)($1.26)($1.26)$2.00 million$3.46 millionN/A
5/8/20183/31/2018($2.22)($3.12)($3.12)$2.04 million$3.35 millionN/A
2/5/2018Q1 2018($2.03)($2.43)($2.43)$2.18 million$7.73 millionN/A
12/4/2017Q4 2017($1.73)($2.18)($2.18)$2.50 million$2.86 millionN/A
8/7/20176/30/2017($1.73)($2.07)($2.07)$2.10 million$3.14 millionListen
5/9/20173/31/2017($1.50)($1.70)($1.70)$2.07 million$2.04 millionListen
2/7/2017Q117($1.35)($0.77)($0.77)$1.85 million$2.54 millionListen
12/5/2016Q416($1.48)($0.89)($0.89)$2.85 million$2.16 millionListen
8/9/2016Q3 2016($1.73)($0.73)($0.73)$3.36 million$3.10 millionN/A
5/5/2016Q2 2016($1.71)($1.10)($1.10)$6.86 million$3.81 millionN/A
2/10/2016Q116($1.53)($0.10)($1.20)$4.61 million$5.40 millionListen
12/7/2015Q415($1.38)($0.85)($0.85)$15.00 million$5.60 millionN/A
8/6/2015Q315($1.30)($1.60)($1.60)$12.82 million$13.55 millionN/A
5/11/2015Q215($1.23)($0.58)($0.58)$11.38 million$9.43 millionListen
2/4/2015Q115($0.91)($0.26)($0.26)$12.12 million$12.40 millionN/A
12/2/2014Q414($0.46)$0.02$0.02$9.15 million$12.03 millionN/A
8/6/2014Q314($0.62)($0.66)($0.66)$12.88 million$13.00 millionN/A
5/7/2014Q114($0.30)$0.49$1.47$12.48 million$12.55 millionN/A
2/5/2014Q1 2014($0.39)($0.31)($0.31)$11.54 million$7.49 millionN/A
11/19/2013Q4 2013($0.19)($0.29)($0.29)$11.42 million$11.52 millionListen
8/5/2013Q3 2013($0.03)($0.24)($0.24)$10.71 million$11.04 millionN/A
6/3/2013Q2 2013($0.26)($0.26)$11.76 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 9/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.